Patents by Inventor Fyodor N. Zolotaryov

Fyodor N. Zolotaryov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230323326
    Abstract: The present invention relates to a mutant of human ?-N-acetylglucosaminidase (hNAGLU), more specifically a hNAGLU mutant produced by adding a mutation to an amino acid sequence for hNAGLU such that an expression level of hNAGLU in a host cell in which a gene encoding hNAGLU is introduced can be increased compared with the case where a gene encoding wild-type hNAGLU is introduced. For example, the hNAGLU mutant has an amino acid sequence represented by SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 9, SEQ ID NO: 11, SEQ ID NO: 15, or SEQ ID NO: 19, or has an amino acid sequence introduced a mutation to the amino acid sequence of any one of the hNAGLU mutants.
    Type: Application
    Filed: August 27, 2021
    Publication date: October 12, 2023
    Applicant: JCR Pharmaceuticals Co., Ltd.
    Inventors: Kenichi Takahashi, Saki Kubota, Fyodor N. Zolotaryov
  • Publication number: 20030171569
    Abstract: A novel human tumor suppressor gene coding for a tumor suppressor protein and whose expression is inhibited by human growth hormone. The DNA composing the gene, and the protein coded by the gene are also provided. The DNA has a nucleotide sequence set forth under SEQ ID NO:1 or SEQ ID NO:2 in the Sequence Listing.
    Type: Application
    Filed: March 18, 2003
    Publication date: September 11, 2003
    Applicant: JCR PHARMACEUTICALS CO., LTD.
    Inventors: Junichi Koga, Keiko Kono, Fyodor N. Zolotaryov